Search results
The child care cliff that wasn’t
Vox· 17 hours agosaid Democratic Sen. Patty Murray in November, following the expiration of federal Covid-19 subsidies for child care. Democrats and other child care...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Looking back at former Trump fixer on the stand in hush money trial: Who is Michael Cohen?
USA TODAY via Yahoo News· 1 day agoHe started his sentence in May 2019, but was sent home early for house arrest due to the COVID-19 pandemic. Where did Michael Cohen go to law school? Michael ...
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Digital Journal· 15 hours ago...terms or at all and other matters that could affect the availability or commercial potential of Aptevo's product candidates, business or economic disruptions due to catastrophes or other events, including natural disasters or public health crises such as the coronavirus (referred to as COVID-19),...
Citi lifts AMC stock target to $3.20 as shares surge 175% in 2 days
Investing.com· 23 hours agoCiti lifts AMC stock target to $3.20 as shares surge 175% in 2 days
Icahn Enterprises L.P. Announces Upsizing and Pricing of Senior Notes
The Herald-News· 1 day agoIcahn Enterprises L.P. (NASDAQ: IEP) – Icahn Enterprises L.P. ("Icahn Enterprises") announced today that it, together with Icahn Enterprises Finance Corp. (together with Icahn ...
Icahn Enterprises L.P. Intends to Offer New Senior Notes
The Herald-News· 2 days agoIcahn Enterprises L.P. (NASDAQ: IEP) – Icahn Enterprises L.P. ("Icahn Enterprises") announced today that it, together with Icahn Enterprises Finance Corp. (together with Icahn ...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges
Investing.com· 2 days agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 1 day agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Phoenix Certified 24-Hour New Construction Home Inspections For Buyers--Update
Digital Journal· 4 days ago...Duty Headache Racks For Dodge & Chevrolet: Truck Accessories Update Phoenix Small Business Content Marketing: Done-For-You...Autocomplete Optimization For Personal Injury Lawyers Announced COVID-19 Self-Employed Tax Credit Refund: Retroactive Claim ...